Fidelity reports investment in STADA
01/17/2003 . Press Release
Bad Vilbel – STADA Arzneimittel AG reports the following pursuant to section 25 (1) of the German Securities Trading Act (WpHG): Fidelity International Limited has reported pursuant to section 21 (1) of the German Securities Trading Act (WpHG) that Fidelity Funds – SICAV held more than 5% of the voting shares of STADA Arzneimittel AG on January 14, 2003. The above-mentioned fund now holds 1,090,555 registered STADA common shares, corresponding to 5.45% of its voting stock.
The remaining shares of STADA Arzneimittel AG continue to be held in free float.
Fidelity International Limited has now fallen below the 5% threshold again. Click here for further information on the current shareholder structure.
For more information, please contact:
STADA Arzneimittel AG
D-61118 Bad Vilbel
Tel.: +49 6101 603-113
Fax: +49 6101 603-506